Results 211 to 220 of about 80,731 (303)

Renin-Angiotensin-Aldosteron-System [PDF]

, 2019
openaire   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Different Polymorphisms of the Renin-Angiotensin-Aldosterone System Genes are Associated with Poorer Blood Pressure Control in Hypertensive Older Adults. [PDF]

High Blood Press Cardiovasc Prev
Freire IV, Ribeiro IJS, Casotti CA, Andrade D, Bezerra DD, Teixeira JRB, Barbosa AAL, Campos LCG, Pereira R.   +8 more
europepmc   +1 more source

Early Persistent Kidney Injury and Long‐Term Outcomes Following Lung Transplantation

Clinical Transplantation, Volume 40, Issue 6, June 2026.
ABSTRACT Introduction Acute kidney injury (AKI) following lung transplantation is associated with long‐term outcomes. Although AKI is diagnosed based on absolute creatinine, this level may not reliably reflect kidney function due to reduced muscle mass in this population.
Kyosuke Dozono, Akinori Maeda, Yoshihisa Shimada, Ryota Inokuchi, Toshifumi Asada, Yohei Komaru, Teruhiko Yoshida, Mitsuaki Kawashima, Chihiro Konoeda, Masaaki Sato, Kent Doi   +10 more
wiley   +1 more source

Effects of SGLT-2 inhibitors on renin-angiotensin-aldosterone system and their correlation with glucose metabolism in type 2 diabetes mellitus patients with hypertension: A prospective study. [PDF]

PLoS One
Wang N, Kong J, Lu Z, Cao F, Tian E, Li J, Li S, Liu S, Yue B.   +8 more
europepmc   +1 more source

Respiratory Biomarkers: An Opportunity for Patient‐Centric Microsampling Approach for Treatment Optimization

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
Overview of patient centric microsampling approach for monitoring respiratory biomarkers for treatment optimization. Image created in BioRender. Khan, A. (2026) https://BioRender.com/17jm5cs. ABSTRACT The clinical heterogeneity of respiratory disorders emphasizes the need for personalized approaches to prevention, diagnosis, and therapy.
Ahmar Khan, Jacqueline L. Stair, Daniel Baker, Neil Spooner, Darragh Murnane   +4 more
wiley   +1 more source

Obstructive sleep apnoea is associated with accelerated progression of diabetic kidney disease

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Aim Persons with type 2 diabetes and diabetic kidney disease (DKD) are at high risk of end‐stage kidney disease or death. We investigated the possible contribution of obstructive sleep apnoea (OSA) to decline in kidney function and renal outcomes.
Sebastian Nielsen, Martin B. Thomsen, Jakob Nyvad, Esben Laugesen, Erik Lerkevang Grove, Per Løgstrup Poulsen, Kent Lodberg Christensen, Mads Vaarby Sørensen, Peder Berg, Niels Henrik Buus   +9 more
wiley   +1 more source

Impact of Renin-Angiotensin-Aldosterone System Modulation on Cognitive and Neuropsychiatric Outcomes: A Systematic Review of Clinical and Mechanistic Evidence. [PDF]

Cureus
Subhani MK, Sabani A, Omer O, Kheirelsid F, Srour AK.   +4 more
europepmc   +1 more source

Kinetic and structural characterisation of domain‐specific angiotensin I‐converting enzyme inhibition by captopril, rentiapril and zofenoprilat

The FEBS Journal, Volume 293, Issue 11, Page 3399-3414, June 2026.
Angiotensin I‐converting enzyme (ACE) contains two catalytic domains (nACE and cACE) and is a key therapeutic target for hypertension and cardiovascular disease. Current ACE inhibitors (ACEi) nonselectively inhibit both domains, causing adverse effects. Selective inhibition requires an understanding of domain‐specific binding.
Kyle S. Gregory, Vinasha Ramasamy, Edward D. Sturrock, K. Ravi Acharya   +3 more
wiley   +1 more source

Epigenetic Regulation of the Renin-Angiotensin-Aldosterone System in Hypertension. [PDF]

Int J Mol Sci
Takeda Y, Demura M, Yoneda T, Takeda Y.
europepmc   +1 more source